Former President Biden’s pre-emptive pardon for retired Gen. Mark Milley, the former chairman of the Joint Chiefs of Staff, will give the retired military official a shield against any action that President Trump might take against him amid their highly public feud.
As one of his final acts in office, President Joe Biden has granted pardons to several people who have faced threats of prosecution from Biden's political opponents. The post ‘The lifeblood of our democracy’: Biden issues last-minute pardons to Fauci,
US President Joe Biden has issued preemptive pardons for former Chairman of the Joint Chiefs of Staff General Mark Milley, Dr. Anthony Fauci, and mem
Gen. Mark Milley, the now-retired former chairman of the Joint Chiefs of Staff, commented on the pardon he received in Biden's final hours in office.
Milley, who served as chairman of the Joint Chiefs of Staff during ... Fauci, who served as director of the National Institute of Allergy and Infectious Diseases for nearly four decades, became ...
Mark Milley, the former chairman of the Joint Chiefs of Staff ... former director of the National Institute of Allergy and Infectious Diseases; some of Biden’s family members, and members ...
President Trump’s decision to pull out of the international health agency could deprive the United States of crucial scientific data and lessen the country’s influence in setting a global health agenda.
Just before leaving office on 24 January, President Joe Biden announced a pre-emptive pardon for Anthony Fauci and other high ranking officials, forgiving them for any misdeeds they might have committed.
Dr. Matthew Memoli, a National Institute of Allergy and Infectious Diseases researcher focused on flu and other respiratory viruses, has been named acting director of the nearly $50 billion agency.
Researchers identified a key protein as a potential therapeutic target for stopping the body's immune system from mistakenly attacking itself, offering new hope for treating autoimmune diseases and allergies.
The Trump administration has appointed Matthew Memoli, a veteran researcher who was critical of the U.S. response to the Covid pandemic, as acting head of the NIH.
The pair of mandates will effectively silo U.S. public health agencies from their international counterparts and sever the American public, health providers, and research hubs from information about infectious diseases, budding epidemics, and even outbreaks of foodborne and waterborne illnesses.